Silverback Therapeutics Correlations

SPRY Stock

13.11 1.18 8.26%

The current 90-days correlation between Silverback Therapeutics and Icosavax is 0.1 (i.e., Average diversification). The correlation of Silverback Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Silverback Therapeutics Correlation With Market

Weak diversification

The correlation between Silverback Therapeutics and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Silverback Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silverback Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Silverback Stock please use our How to Invest in Silverback Therapeutics guide.

Moving together with Silverback Stock

0.82	JNJ	Johnson Johnson	Pair Corr
0.74	UPC	Universe Pharmaceuticals	Pair Corr
0.87	AMGN	Amgen Inc Earnings Call This Week	Pair Corr
0.83	ENSG	Ensign Group	Pair Corr
0.83	CVS	CVS Health Corp Earnings Call This Week	Pair Corr
0.7	EHC	Encompass Health Corp Earnings Call This Week	Pair Corr
0.76	INNV	InnovAge Holding Corp Earnings Call This Week	Pair Corr
0.8	PNTG	Pennant Group	Pair Corr
0.75	301301	Yili Chuanning Biote	Pair Corr

Moving against Silverback Stock

0.62	ALTS	ALT5 Sigma Symbol Change	Pair Corr
0.47	BFRI	Biofrontera	Pair Corr
0.37	LFCR	Lifecore Biomedical	Pair Corr
0.7	LPTH	LightPath Technologies Earnings Call This Week	Pair Corr
0.62	VIST	Vista Oil Gas	Pair Corr
0.6	PLTR	Palantir Technologies Earnings Call This Week	Pair Corr
0.37	BAMXF	Bayerische Motoren Werke	Pair Corr
0.37	GILT	Gilat Satellite Networks	Pair Corr
0.31	V	Visa Class A	Pair Corr

Related Correlations Analysis

	ZURA	ANNX	ICVX	INAB	WVE	PALI	CFRX	ALLR	CNSP	WINT
ZURA		0.97	-0.85	0.38	0.72	0.86	0.57	0.67	0.59	0.92	ZURA
ANNX	0.97		-0.85	0.3	0.61	0.85	0.61	0.64	0.58	0.9	ANNX
ICVX	-0.85	-0.85		-0.25	-0.39	-0.82	-0.45	-0.82	-0.53	-0.8	ICVX
INAB	0.38	0.3	-0.25		0.39	0.37	0.04	0.19	0.28	0.35	INAB
WVE	0.72	0.61	-0.39	0.39		0.53	0.45	0.34	0.42	0.7	WVE
PALI	0.86	0.85	-0.82	0.37	0.53		0.47	0.6	0.66	0.93	PALI
CFRX	0.57	0.61	-0.45	0.04	0.45	0.47		0.19	0.4	0.59	CFRX
ALLR	0.67	0.64	-0.82	0.19	0.34	0.6	0.19		0.4	0.58	ALLR
CNSP	0.59	0.58	-0.53	0.28	0.42	0.66	0.4	0.4		0.62	CNSP
WINT	0.92	0.9	-0.8	0.35	0.7	0.93	0.59	0.58	0.62		WINT
	ZURA	ANNX	ICVX	INAB	WVE	PALI	CFRX	ALLR	CNSP	WINT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ANNX	+ 0.97	ZURA
WINT	+ 0.93	PALI
WINT	+ 0.92	ZURA
WINT	+ 0.9	ANNX
PALI	+ 0.86	ZURA
PALI	+ 0.85	ANNX

High negative correlations

ICVX	- 0.85	ANNX
ICVX	- 0.85	ZURA
ALLR	- 0.82	ICVX
PALI	- 0.82	ICVX
WINT	- 0.8	ICVX
CNSP	- 0.53	ICVX

Risk-Adjusted Indicators

There is a big difference between Silverback Stock performing well and Silverback Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Silverback Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZURA	4.40	(1.27)	0.00	9.27	0.00	0.00	9.21	(11.55)	25.04
ANNX	2.61	(0.86)	0.00	109.05	0.00	0.00	5.45	(6.65)	22.26
ICVX	4.87	0.93	0.18	1.12	4.56	(5.67)	10.22	(6.79)	38.57
INAB	5.09	(0.18)	0.00	(0.21)	0.00	0.00	11.54	(10.81)	36.85
WVE	3.01	(0.27)	0.00	(0.73)	0.00	0.00	7.43	(8.06)	20.98
PALI	5.83	(0.95)	0.00	13.08	0.00	0.00	12.73	(12.26)	93.57
CFRX	5.26	(0.17)	0.00	0.25	0.00	0.00	12.23	(8.45)	55.69
ALLR	4.38	(0.16)	0.00	(0.50)	0.00	0.00	6.93	(8.33)	37.19
CNSP	4.37	(0.32)	0.00	0.38	0.00	0.00	10.00	(9.09)	24.15
WINT	4.38	(2.66)	0.00	(5.89)	0.00	0.00	8.93	(11.59)	32.37

Silverback Therapeutics Corporate Management

MD MBA	CoFounder Officer	Profile
Kathleen CPA	Chief Officer	Profile
Alexander Esq	Chief Secretary	Profile
Daniel Relovsky	Senior Marketing	Profile
Eric Karas	Chief Officer	Profile
Justin Chakma	Chief Secretary	Profile
Brian MS	SVP Management	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC